Four-year antibody persistence and response to a booster dose of a pentavalent MenABCWY vaccine administered to healthy adolescents and young adults

• Hauptverfasser: Xavier Sáez-Llorens (Verfasst von), Johnny Beltran-Rodriguez (Verfasst von), Jose M. Novoa Pizarro (Verfasst von), Ilhem Mensi (Verfasst von), Pavitra Keshavan (Verfasst von), Daniela Toneatto (Verfasst von)
• Format: Buch
• Veröffentlicht: Taylor & Francis Group, 2018-05-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

This open-label, multicenter extension study (NCT02451514) assessed persistence of Neisseria meningitidis serogroups ABCWY antibodies 4 years after primary vaccination. Adolescents and young adults who previously received 2 doses of MenABCWY+OMV (Group III), 1 dose of MenACWY-CRM (Group VI), or newl...